The present invention exploits the discovery that amounts of uracil and thymine metabolites, especially .beta.-aminoisobutyric acid, in various bodily fluids, especially urine, are correlated with the occurrence of epilepsy when compared to matched control subjects. Analytical and diagnostic protocols, including a novel high performance liquid chromatography system, for use in the invention are disclosed.

 
Web www.patentalert.com

< Lipid encapsulated interfering RNA

< Hybrid adenovirus/adeno-associated virus vectors and methods of use thereof

> Transgenesis by sperm-mediated gene transfer

> Compositions and methods for gene silencing

~ 00232